The global small animal imaging (in-vivo) market size is expected to reach USD 1.87 billion by 2030, expanding at a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period.
Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging.
Request a free sample copy or view report summary: Small Animal Imaging (In-vivo) Market Report
Optical imaging was the largest segment in 2023 owing to rapid and easy operations and relatively cost-effective in comparison to other devices
Micro-MRI technology is anticipated to be the fastest growing segment over the forecast period due varied applications during anatomical and functional analysis in developing mouse embryos and neonates
In 2023, bio-distribution and monitoring the treatment response dominated the market in terms of revenue
The cancer cell detection segment is expected to show substantial growth due to the increasing prevalence of cancer and rising government initiatives for cancer diagnostics research
North America was the largest region in terms of revenue in 2023. Vast pre-clinical research, increasing demand for rapid and advanced methods, established healthcare infrastructure, and favorable platform for R&D pertaining to technological advancements are the key factors driving the regional market
Europe was the second largest region in 2023, due to a large number of clinical research and pharmaceutical organizations and diagnostic device manufacturers
Asia Pacific is projected to be the fastest growing region over the forecast period owing to increasing clinical research activities, rising base of target population, and emerging economies
Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; PerkinElmer, Inc.; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd
Grand View Research has segmented the global small animal imaging (in-vivo) market based on component, modality, application, and region :
Small Animal Imaging (In-vivo) Modality Outlook (Revenue, USD Million, 2018 - 2030)
Optical Imaging Systems
Bioluminescence Imaging
Cerenkov Luminescence Imaging
Fluorescence Imaging
Micro-magnetic Resonance Imaging
Nuclear Imaging
Micro Positron Emission Tomography (Micro PET)
Micro Single Photon Emission Computerized Tomography (Micro SPECT)
Other Imaging Modalities
Micro Computerized Tomography Imaging
Micro Ultrasound Imaging
Small Animal Imaging (In-vivo) Application Outlook (Revenue, USD Million, 2018 - 2030)
Monitoring Drug Treatment Response
Biodistribution Studies
Cancer Cell Detection
Biomarkers
Longitudinal Studies
Epigenetics
Small Animal Imaging (In-vivo) Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Small Animal Imaging (In-vivo) Market
Aspect Imaging Ltd.
PerkinElmer, Inc.
FUJIFILM Holdings Corporation
Miltenyi Biotec
Thermo Fisher Scientific Inc.
Bruker
Siemens AG
Promega Corporation
Mediso
"The quality of research they have done for us has been excellent..."